News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here .

Recommended Reading

Perianal Basal Cell Carcinoma Treated With Mohs Micrographic Surgery
MDedge Dermatology
Secukinumab Emerges as a Rapidly Effective Therapy for Pityriasis Rubra Pilaris
MDedge Dermatology
Discoid Lupus Erythematosus Following Herpes Zoster
MDedge Dermatology
Squamoid Eccrine Ductal Carcinoma
MDedge Dermatology
Collagen remodeling observed after laser treatment in EB patient
MDedge Dermatology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Dermatology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Dermatology
RFPs Available for the Study of Three Rare Diseases
MDedge Dermatology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Dermatology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Dermatology